[1]
E. D. Ahire and S. J. Kshirsagar, “Irinotecan’s molecular mechanisms against cancer: a primary system biology and chemoinformatics approach for novel formulation development”, Curr. Issues Pharm. Med. Sci., vol. 38, no. 1, pp. 31–37, Apr. 2025, doi: 10.12923/cipms-2025-0005.